Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study.
Journal: Frontiers in oncology
Published: January 05, 2025
AI-Generated Draft Replies Integrated Into Health Records and Physicians' Electronic Communication.
Journal: JAMA network open
Published: April 15, 2024
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Journal: Breast cancer research : BCR
Published: March 14, 2024
Let's TOC Fertility: A stepped wedge cluster randomized controlled trial of the Telehealth Oncofertility Care (TOC) intervention in children, adolescent and young adult cancer survivors.
Journal: Contemporary clinical trials
Published: December 15, 2023
A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic Her2-negative breast cancer.
Journal: Breast cancer research : BCR
Published: October 27, 2023
Development, Usability Testing, and Implementation Assessment of Cancer Related Infertility Score Predictor, an Online Cancer Related Infertility Risk Counseling Tool.
Journal: Journal of adolescent and young adult oncology
Published: May 15, 2023
Association of physician burnout with perceived EHR work stress and potentially actionable factors.
Journal: Journal of the American Medical Informatics Association : JAMIA
Published: February 14, 2023
A Multicomponent Telehealth Intervention to Improve Oncofertility Care Delivery Among Young Cancer Patients: A Pilot Study.
Journal: Journal of adolescent and young adult oncology
Published: May 31, 2022
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b Study.
Journal: Frontiers in oncology
Published: November 05, 2021
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Journal: JAMA oncology
Published: September 16, 2021
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Journal: Nature communications
Published: March 25, 2021
Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 24, 2021
Last Updated: 09/26/2026